Rani Therapeutics (RANI)
(Delayed Data from NSDQ)
$2.18 USD
-0.16 (-6.84%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $2.29 +0.11 (5.05%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMRani Therapeutics Holdings, Inc. (RANI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.75 | $17.00 | $8.00 | 402.14% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Rani Therapeutics Holdings, Inc. comes to $11.75. The forecasts range from a low of $8.00 to a high of $17.00. The average price target represents an increase of 402.14% from the last closing price of $2.34.
Analyst Price Targets (8 )
Broker Rating
Rani Therapeutics Holdings, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, eight are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | Cantor Fitzgerald & Co | Olivia Brayer | Strong Buy | Strong Buy |
8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/25/2024 | H.C. Wainwright & Co. | Mitchell S Kapoor | Strong Buy | Strong Buy |
6/13/2024 | Maxim Group | Michael Okunewitch | Not Available | Strong Buy |
5/16/2024 | UBS | Ashwani Verma | Strong Buy | Strong Buy |
5/9/2024 | BTIG | Julian Harrison | Strong Buy | Strong Buy |
3/27/2024 | Canaccord Genuity | Edward H Nash | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 8 |
Average Target Price | $11.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -0.22 |
RANI FAQs
Rani Therapeutics Holdings, Inc. (RANI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Rani Therapeutics Holdings, Inc. (RANI) is $11.75. The current on short-term price targets is based on 4 reports.
The forecasts for Rani Therapeutics Holdings, Inc. (RANI) range from a low of $8 to a high of $17. The average price target represents a increase of $438.99 from the last closing price of $2.18.
The current UPSIDE for Rani Therapeutics Holdings, Inc. (RANI) is 438.99%
Based on short-term price targets offered by eight analysts, the average price target for Rani Therapeutics Holdings, Inc. comes to $11.75. The forecasts range from a low of $8.00 to a high of $17.00. The average price target represents an increase of 402.14% from the last closing price of $2.34.